目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Drug and Gene Delivery Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Drug and Gene Delivery Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Drug and Gene Delivery Devices Market: Route of Administration Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Drug and Gene Delivery Devices: Route of Administration Outlook Analysis, 2023 & 2030 (USD Million)
4.3. Oral
4.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Inhalation
4.4.1. Inhalation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Transdermal
4.5.1. Transdermal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Injectable
4.6.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Ocular
4.7.1. Ocular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Nasal
4.8.1. Nasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Topical
4.9.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug and Gene Delivery Devices Market: Vector Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Drug and Gene Delivery Devices Market: Vector Analysis, 2023 & 2030 (USD Million)
5.3. Viral
5.3.1. Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-Viral
5.4.1. Non-Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Drug and Gene Delivery Devices Market: Regional Estimates & Trend Analysis
6.1. Drug and Gene Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Uniqure N.V.,
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. SiBiono GeneTech Co.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Epeius Biotechnologies Corporation
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Shanghai Sunway Biotech Co., Ltd
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Pfizer, Inc.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. F. Hoffmann-La Roche Ltd.
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.7. Johnson and Johnson
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Novartis AG
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Bayer AG
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Becton, Dickinson and Company
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives